{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=New%20Vitalis%2C%20LLC%20dba%20New%20Vitalis%20Pharmacy","name":"New Vitalis, LLC dba New Vitalis Pharmacy","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-06T12:40:27.602Z"},"count":1,"matches":[{"id":"9991c61988c94faa","posted_date":"2022-05-31","letter_issue_date":"2022-05-18","company_name":"New Vitalis, LLC dba New Vitalis Pharmacy","issuing_office":"Division of Pharmaceutical Quality Operations III","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.morvs.ai/fda-warning/9991c61988c94faa"}]}